Heart failure (HF)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients aged 18 years or older; 2. Diagnosed with heart failure (HF), including HFrEF, HFmrEF, or HFpEF, based on clinical manifestations and echocardiographic parameters clearly defined in the guidelines; 3. No history of diabetes, with no diabetes diagnosis found in admission or past records, or fasting blood glucose and HbA1c levels not reaching the diagnostic criteria for diabetes; 4. Have received SGLT2 inhibitor treatment for 1 month or more, with complete treatment and follow-up records; 5. Follow-up data are complete, with obtainable information on the timing of prognostic events and outcome data.
Exclusion criteria
Exclusion criteria: 1. Patients with clear diabetes or prediabetes progressing to diabetes. 2. Patients with severe liver or kidney dysfunction (e.g., glomerular filtration rate eGFR < 30 mL/min/1.73 m^2); 3. Patients with severe acute diseases (e.g., acute myocardial infarction, acute pulmonary embolism, acute infection, shock, etc.) that may significantly interfere with prognosis assessment; 4. Patients who have changed key heart failure treatment plans (e.g., ß-blockers, ARNI, etc.) within the past 3 months, resulting in difficulty distinguishing drug effects; 5. Patients lacking key baseline data, such as echocardiography parameters, hematological indicators, follow-up event records, etc.; 6. Patients who withdraw, are lost to follow-up, or have incomplete data during follow-up, making prognosis assessment impossible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Laboratory indicators, such as N-terminal pro B-type natriuretic peptide, serum creatinine, serum potassium, and serum albumin levels;Echocardiography parameters, such as left ventricular eject; | — |
Countries
China
Contacts
The Affiliated Hospital of Xuzhou Medical University